Breaking News Instant updates and real-time market news.

DXCM

DexCom

$132.15

1.25 (0.95%)

16:02
11/06/18
11/06
16:02
11/06/18
16:02

DexCom reports Q3 EPS 17c, consensus (10c)

Reports Q3 revenue $266.7M, consensus $241.3M.

  • 06

    Nov

  • 27

    Nov

DXCM DexCom
$132.15

1.25 (0.95%)

10/19/18
GSCO
10/19/18
UPGRADE
Target $125
GSCO
Neutral
DexCom upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Isaac Ro upgraded DexCom to Neutral and raised his price target for the shares to $125 from $74. The analyst says his Sell thesis has not worked, with DexCom shares up 84.1% since his April 4 downgrade to Sell. Ro now believes the G5/G6 upgrade cycle will continue to be stronger than he previously expected based on his review of various resources including app data, channel checks, and management commentary. However, he's not taking a bullish view on DexCom as he believes competition and pricing will continue to intensify.
10/19/18
GSCO
10/19/18
DOWNGRADE
Target $44
GSCO
Sell
Nevro downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Isaac Ro downgraded Nevro (NRVO) to Sell and lowered his price target for the shares to $44 from $60. The company's cycle of negative estimate revisions is not yet over, Ro tells investors in a research note where he also upgraded DexCom (DXCM) to Neutral. The analyst thinks consensus revenue expectations for Nevro are still too high amid "ramping" competition, the company's ongoing patent litigation with Boston Scientific (BSX) and the hiring disruption in its sales force.
10/29/18
PIPR
10/29/18
NO CHANGE
PIPR
Overweight
Piper says any positive news on DexCom in non-intensive will be well received
Piper Jaffray analyst JP McKim noted to investors that the FDA website shows that Dexcom got 510K approval for an "integrated continuous glucose monitoring system for non-intensive diabetes management" called the Dexcom G6 Glucose Program Continuous Glucose Monitoring System on October 26. While he is unclear how the system is different from the currently marketed device, he notes the 501K application specifically states it is intended to replace finger stick testing for people who do not have a significant risk of hypoglycemia. McKim, who believes the company is moving beyond just providing the most accurate CGM chart into technology services, finds it interesting that the filing states the device "can be used alone or in conjunction with digitally connected devices or services," he tells investors. McKim expects to hear more about this 510K approval on the company's earnings call next week or at its analyst day in early December and thinks any positive update on the non-intensive diabetes population will be well received by investors. He keeps an Overweight rating on DexCom shares.
11/05/18
PIPR
11/05/18
NO CHANGE
Target $150
PIPR
Overweight
DexCom clearly 'making moves' in iCGM pathway, says Piper Jaffray
Piper Jaffray analyst JP McKim noted that the FDA website shows that Dexcom got 510K approval for an "integrated continuous glucose monitoring system for non-intensive diabetes management" and said the number one question he got was if this was the Verily product. He thinks a newly released summary document implies that it is not, but instead a product specific for those without significant risk of hypoglycemia. McKim, who expects to hear a lot more on the company's earnings call tomorrow night, said that "what is clear is that [Dexcom] is making moves." He sees the earnings call tomorrow night setting up for a lot of new updates that he thinks will be positively received and keeps an Overweight rating and $150 price target on Dexcom ahead of the event.

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$0.00

(0.00%)

05:51
11/14/18
11/14
05:51
11/14/18
05:51
Hot Stocks
Daimler to open new R&D center in China to accelerate localization »

Daimler announced plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$37.04

-1.04 (-2.73%)

, MO

Altria Group

$60.01

-1.18 (-1.93%)

05:46
11/14/18
11/14
05:46
11/14/18
05:46
Hot Stocks
Juul to halt social media promotions, stop selling most flavors in stores »

Juul Labs said in a…

BTI

British American Tobacco

$37.04

-1.04 (-2.73%)

MO

Altria Group

$60.01

-1.18 (-1.93%)

PM

Philip Morris

$86.42

-1.48 (-1.68%)

FB

Facebook

$142.19

0.67 (0.47%)

SNAP

Snap

$6.72

0.06 (0.90%)

TWTR

Twitter

$32.49

0.49 (1.53%)

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

AIBRF

AIB Group

$0.00

(0.00%)

05:44
11/14/18
11/14
05:44
11/14/18
05:44
Upgrade
AIB Group rating change  »

AIB Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$192.23

-1.925 (-0.99%)

, LITE

Lumentum

$38.95

1.445 (3.85%)

05:42
11/14/18
11/14
05:42
11/14/18
05:42
Recommendations
Apple, Lumentum, Qorvo analyst commentary  »

UBS drops Apple price…

AAPL

Apple

$192.23

-1.925 (-0.99%)

LITE

Lumentum

$38.95

1.445 (3.85%)

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AMZN

Amazon.com

$1,631.68

-5.02 (-0.31%)

05:38
11/14/18
11/14
05:38
11/14/18
05:38
Periodicals
Amazon decided to split HQ2 in two in September, WSJ reports »

Amazon officials made the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Nov

  • 04

    Dec

RMED

Ra Medical Systems

$8.16

-0.455 (-5.28%)

05:33
11/14/18
11/14
05:33
11/14/18
05:33
Recommendations
Ra Medical Systems analyst commentary  »

Piper recommends purchase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

REGN

Regeneron

$342.12

-4.45 (-1.28%)

05:30
11/14/18
11/14
05:30
11/14/18
05:30
Recommendations
Regeneron analyst commentary  »

Regeneron survey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 11

    Mar

  • 28

    Apr

  • 13

    May

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

, TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

05:28
11/14/18
11/14
05:28
11/14/18
05:28
Hot Stocks
Pan American Silver to acquire Tahoe Resources for $3.40 per share »

Pan American Silver…

PAAS

Pan American Silver

$14.13

-0.14 (-0.98%)

TAHO

Tahoe Resources

$2.20

-0.055 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$36.88

0.46 (1.26%)

05:20
11/14/18
11/14
05:20
11/14/18
05:20
Earnings
Breaking Earnings news story on Biohaven Pharmaceutical »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 27

    Nov

BRKR

Bruker

$32.65

-0.21 (-0.64%)

05:19
11/14/18
11/14
05:19
11/14/18
05:19
Hot Stocks
Bruker agrees to acquire Alicona Imaging GmbH, terms not disclosed »

Bruker Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$120.29

-1.45 (-1.19%)

05:18
11/14/18
11/14
05:18
11/14/18
05:18
Hot Stocks
Elbit Systems awarded $167M contract from Asia-Pacific country »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FTI

TechnipFMC

$23.53

-1.24 (-5.01%)

, CVX

Chevron

$115.35

-2.12 (-1.80%)

05:16
11/14/18
11/14
05:16
11/14/18
05:16
Hot Stocks
TechnipFMC signs surface technologies frame agreement with Chevron »

TechnipFMC (FTI) has…

FTI

TechnipFMC

$23.53

-1.24 (-5.01%)

CVX

Chevron

$115.35

-2.12 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

05:15
11/14/18
11/14
05:15
11/14/18
05:15
General news
Oil prices erased losses »

Oil prices erased losses…

SERV

ServiceMaster

$43.03

0.545 (1.28%)

05:14
11/14/18
11/14
05:14
11/14/18
05:14
Initiation
ServiceMaster initiated  »

ServiceMaster initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$180.07

-2.08 (-1.14%)

05:13
11/14/18
11/14
05:13
11/14/18
05:13
Initiation
S&P Global initiated  »

S&P Global initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

RENN

Renren

$1.53

0.08 (5.52%)

05:13
11/14/18
11/14
05:13
11/14/18
05:13
Hot Stocks
Renren sells SNS business to Beijing Infinities Interactive Media »

Beijing Infinities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$148.05

-2.03 (-1.35%)

05:12
11/14/18
11/14
05:12
11/14/18
05:12
Initiation
Moody's initiated  »

Moody's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

K

Kellogg

$63.48

-0.81 (-1.26%)

05:08
11/14/18
11/14
05:08
11/14/18
05:08
Downgrade
Kellogg rating change  »

Kellogg downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

WYGPY

WorleyParsons

$0.00

(0.00%)

05:05
11/14/18
11/14
05:05
11/14/18
05:05
Upgrade
WorleyParsons rating change  »

WorleyParsons upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SURRY

Sun Art Retail Group

$0.00

(0.00%)

05:02
11/14/18
11/14
05:02
11/14/18
05:02
Downgrade
Sun Art Retail Group rating change  »

Sun Art Retail Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTT

CatchMark Timber

$9.14

0.045 (0.49%)

04:59
11/14/18
11/14
04:59
11/14/18
04:59
Recommendations
CatchMark Timber analyst commentary  »

CatchMark Timber price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLXN

Flexion

$16.40

0.17 (1.05%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
Flexion management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

04:55
11/14/18
11/14
04:55
11/14/18
04:55
General news
Breaking General news story  »

Federal Reserve Chairman…

CRL

Charles River

$131.47

-2.125 (-1.59%)

, CRVS

Corvus Pharmaceuticals

$7.24

-0.28 (-3.72%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
European Organization for Research & Treatment of Cancer to hold symposium »

The European Organization…

CRL

Charles River

$131.47

-2.125 (-1.59%)

CRVS

Corvus Pharmaceuticals

$7.24

-0.28 (-3.72%)

XCUR

Exicure

$0.00

(0.00%)

ZYME

Zymeworks

$13.04

-0.2 (-1.51%)

ARWR

Arrowhead

$12.48

-0.35 (-2.73%)

ALRN

Aileron Therapeutics

$2.21

0.33 (17.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 27

    Nov

BBT

BB&T

$51.07

0.53 (1.05%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
BB&T to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.